EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-analysis of randomized controlled trials

Shige Li, Bing Dai, Yusheng Hou, Liang Zhang, Jie Liu, Haijia Hou, Dandan Song, Shengchen Wang, Xiangrui Li, Hongwen Zhao, Wei Wang, Jian Kang und 1 weitere

Therapeutic Advances in Respiratory Disease · 2025-01 · 19

DOI: 10.1177/17534666251323482 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 13.03.2025. Verfasst von Shige Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: COVID-19, Lung, Post-Acute COVID-19 Syndrome. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary rehabilitation (PR) has demonstrated efficacy in managing long COVID-19, underscoring the need to refine and tailor PR strategies for optimal patient outcomes.

Objectives

To evaluate the impact of PR on patients with long COVID-19 and to compare the efficacy of different types and durations of PR interventions.

Design

Systematic review and meta-analysis. Data sources and methods: We systematically searched randomized controlled trials (RCTs) of the effectiveness of PR in long COVID-19 patients published before April 2024. The primary outcomes were physical capacity assessed by the 6-minute walking test (6MWT), lung function measured by forced expiratory volume in the first second (FEV1) and forced vital capacity (FVC), health-related quality of life (HRQoL), and fatigue. Secondary outcomes were thirty-second sit-to-stand test (30STST), handgrip strength tests, maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), dyspnea, depression, anxiety, perceived effort, and adverse events.

Results

A total of 37 studies with 3363 patients were included. Compared to controls, PR improved physical capacity (6MWT, 30STST, handgrip), lung function (FEV1, FVC, MIP, MEP), HRQoL, fatigue, dyspnea, and anxiety but did not reach statistical significance for depression. Subgroup analyses of PR duration indicated that programs of ⩽4 weeks improved 6MWT; those between 4 and 8 weeks significantly improved 6MWT, lung function (FEV1, FVC), HRQoL, and reduced fatigue; and programs over 8 weeks improved HRQoL and reduced fatigue. Exercise type analysis revealed that breathing exercises improved 6MWT, lung function (FEV1, FVC), and HRQoL; multicomponent exercises enhanced 6MWT performance and reduced fatigue; the combination of both types improved 6MWT, FEV1 (L), FVC (%pred), HRQoL, and reduced fatigue.

Conclusion

PR improves physical capacity, lung function, and quality of life and alleviates dyspnea, fatigue, and anxiety in long COVID-19 patients. A 4- to 8-week PR program and a combination of both breath exercises and multicomponent training is most effective for managing long-term COVID-19 syndromes.

Trial registration

PROSPERO ID: CRD42024455008.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19LungPost-Acute COVID-19 SyndromeHumansExercise ToleranceQuality of LifeRandomized Controlled Trials as TopicRecovery of FunctionRespiratory Function TestsTime FactorsTreatment OutcomeWalk Test

Stichwörter der Autor:innen

exerciselong COVID-19pulmonary rehabilitation

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Department of Endocrinology, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Department of Rehabilitation Medicine, The People's Hospital of Liaoning Province, Shenyang, China.
  • Department of Health Statistics, School of Public Health, China Medical University, Shenyang, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang 110000, China.

ORCID-Profile: Wei Tan

Förderung

  • China Postdoctoral Science Foundation

Zitieren

APA

Li, S., Dai, B., Hou, Y., Zhang, L., Liu, J., Hou, H., Song, D., Wang, S., Li, X., Zhao, H., Wang, W., Kang, J., & Tan, W. (2025). Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-analysis of randomized controlled trials. Therapeutic Advances in Respiratory Disease, 19. https://doi.org/10.1177/17534666251323482

Vancouver

Li S, Dai B, Hou Y, Zhang L, Liu J, Hou H, et al. Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-analysis of randomized controlled trials. Therapeutic Advances in Respiratory Disease. 2025;19. doi:10.1177/17534666251323482

BibTeX
@article{Li2025,
  author = {Li, Shige and Dai, Bing and Hou, Yusheng and Zhang, Liang and Liu, Jie and Hou, Haijia and Song, Dandan and Wang, Shengchen and Li, Xiangrui and Zhao, Hongwen and Wang, Wei and Kang, Jian and Tan, Wei},
  title = {Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-analysis of randomized controlled trials},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2025},
  volume = {19},
  doi = {10.1177/17534666251323482}
}
Kostenlos starten →